These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 18368051)

  • 1. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
    Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
    Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of microRNAs for therapeutics.
    Stenvang J; Lindow M; Kauppinen S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
    Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
    Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA silencing in primates: towards development of novel therapeutics.
    Petri A; Lindow M; Kauppinen S
    Cancer Res; 2009 Jan; 69(2):393-5. PubMed ID: 19147547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of microRNAs in vivo with 'antagomirs'.
    Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
    Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An LNA-based loss-of-function assay for micro-RNAs.
    Naguibneva I; Ameyar-Zazoua M; Nonne N; Polesskaya A; Ait-Si-Ali S; Groisman R; Souidi M; Pritchard LL; Harel-Bellan A
    Biomed Pharmacother; 2006 Nov; 60(9):633-8. PubMed ID: 16962735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
    Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
    Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.
    Rottiers V; Obad S; Petri A; McGarrah R; Lindholm MW; Black JC; Sinha S; Goody RJ; Lawrence MS; deLemos AS; Hansen HF; Whittaker S; Henry S; Brookes R; Najafi-Shoushtari SH; Chung RT; Whetstine JR; Gerszten RE; Kauppinen S; Näär AM
    Sci Transl Med; 2013 Nov; 5(212):212ra162. PubMed ID: 24259050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of microRNAs by Northern blot analyses using LNA probes.
    Várallyay E; Burgyán J; Havelda Z
    Methods; 2007 Oct; 43(2):140-5. PubMed ID: 17889801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primate microRNAs miR-220 and miR-492 lie within processed pseudogenes.
    Devor EJ
    J Hered; 2006; 97(2):186-90. PubMed ID: 16489141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
    Xia H; Qi Y; Ng SS; Chen X; Li D; Chen S; Ge R; Jiang S; Li G; Chen Y; He ML; Kung HF; Lai L; Lin MC
    Brain Res; 2009 May; 1269():158-65. PubMed ID: 19265686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A miRNA signature of prion induced neurodegeneration.
    Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
    PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
    Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
    Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target identification of microRNAs expressed highly in human embryonic stem cells.
    Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
    J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice.
    Roberts J; Palma E; Sazani P; Ørum H; Cho M; Kole R
    Mol Ther; 2006 Oct; 14(4):471-5. PubMed ID: 16854630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA detection in bone marrow cells by LNA-FISH.
    Debernardi S; Dixon-McIver A
    Methods Mol Biol; 2010; 667():33-45. PubMed ID: 20827525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.